Methodologic issues concerning Stachyhemolysin and Stachyrase-A as clinical biomarkers [1]

Medical Science Monitor

Volumn 11, Issue 9, 2005, Pages

  Page, Elena H ^a   Biagini, Raymond E ^a   Beezhold, Donald H ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FUNGUS ANTIBODY; FUNGUS ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; STACHYHEMOLYSIN ANTIGEN; STACHYRASE A ANTIGEN; UNCLASSIFIED DRUG;

BLOOD ANALYSIS; CROSS REACTION; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGAL CONTAMINATION; LETTER; METHODOLOGY; NONHUMAN; OPTICAL DENSITY; STACHYBOTRYS CHARTARUM;

ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; BIOLOGICAL MARKERS; HEMOLYSIN PROTEINS; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; SERINE ENDOPEPTIDASES; STACHYBOTRYS;

EID: 24944479409     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Vojdani A. Antibodies against Stachybotrys chartarum extract and its antigenic components, Stachyhemolysin and Stachyrase-A: a new clinical biomarker. Med Sci Monit, 2005; 11(5): BR139-BR145
2. Trout DB, Seltzer JM, Page EH et al: Clinical use of immunoassays in assessing exposure to fungi and potential health effects related to fungal exposure. Ann All Asthma Immun, 2004; 92: 483-92
3. Schmechel D, Simpson JP, Lewis DM: The production and characterization of monoclonal antibodies to the fungus Aspergillus versicolor. Indoor Air, 2005; 15(Suppl.9): 11-19
4. Biagini RE: Epidemiology studies in immunotoxicity evaluations. Toxicology, 1998; 129(1): 37-54
5. Kordula T, Banbula A, Macomson J, Travis J: Isolation and properties of stachyrase A, a chymotrypsin-like serine proteinase from Stachybotrys chartarum. Infect Immun, 2002; 70(1): 419-21
6. Barnes C, Buckley S, Pacheco F, Portnoy J: IgE-reactive proteins from Stachybotrys chartarum. Ann All Asthma Immunol, 2002; 89(1): 29-33